Literature DB >> 17486640

GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma.

John C McHugh1, Brian Murray, Radhakrishnan Renganathan, Sean Connolly, Tim Lynch.   

Abstract

Stiff person syndrome (SPS) is an unusual cause of muscle rigidity and spasms. It is believed to have an autoimmune pathogenesis and is associated with autoantibodies to glutamic acid decarboxylase (GAD). Paraneoplastic SPS (PSPS) has been described mainly in relation to breast cancer and is associated with antibodies to amphiphysin. Few reports of PSPS document the finding of GAD autoantibodies. We present the first reported case of anti-GAD positive PSPS in a 53-year-old male with occult renal carcinoma. Clinical benefit was marked following nephrectomy and intravenous immunoglobulin treatment. Renal carcinoma should be considered in patients with SPS. 2007 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486640     DOI: 10.1002/mds.21374

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

Review 1.  Autoimmune-mediated encephalitis.

Authors:  Philippe Demaerel; Wim Van Dessel; Wim Van Paesschen; Rik Vandenberghe; Koen Van Laere; Jennifer Linn
Journal:  Neuroradiology       Date:  2011-01-27       Impact factor: 2.804

Review 2.  Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.

Authors:  Goran Rakocevic; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

Review 3.  Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.

Authors:  M Hegemann; N Kroeger; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2018-02-10       Impact factor: 4.226

4.  Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

Authors:  M J Titulaer; R Soffietti; J Dalmau; N E Gilhus; B Giometto; F Graus; W Grisold; J Honnorat; P A E Sillevis Smitt; R Tanasescu; C A Vedeler; R Voltz; J J G M Verschuuren
Journal:  Eur J Neurol       Date:  2010-09-29       Impact factor: 6.089

5.  Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.

Authors:  Helena Ariño; Romana Höftberger; Nuria Gresa-Arribas; Eugenia Martínez-Hernández; Thaís Armangue; Michael C Kruer; Javier Arpa; Julio Domingo; Bojan Rojc; Luis Bataller; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

Review 6.  Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

Authors:  Josephe Archie Honorat; Andrew McKeon
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

7.  Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.

Authors:  Macarena Villagrán-García; Sergio Muñiz-Castrillo; Nicolás Lundahl Ciano-Petersen; Alberto Vogrig; Antonio Farina; Marine Villard; Dimitri Psimaras; Agusti Alentorn; David Gonçalves; Nicole Fabien; Véronique Rogemond; Bastien Joubert; Jérôme Honnorat
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

Review 8.  Paraneoplastic movement disorders.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

Review 9.  Antibodies and neuronal autoimmune disorders of the CNS.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  J Neurol       Date:  2009-12-25       Impact factor: 4.849

10.  "Dancing eye syndrome" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer.

Authors:  S Laroumagne; Xavier Elharrar; B Coiffard; J Plojoux; H Dutau; D Breen; P Astoul
Journal:  Case Rep Med       Date:  2014-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.